Table 5.
Multiple regression analysis of salivary ischemia biomarkers in all involved objects.
| NWS | SWS | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XO activity | XO specific activity | XO output | H2O2 concentration | UA concentration | XO activity | XO specific activity | XO output | H2O2 concentration | UA concentration | ||
| β1: stroke type | Estimate | 8.42 | 16.45 | 4.21 | 202.1 | 21.66 | -0.008267 | 2.015 | 1.044 | 20.13 | -13.56 |
| 95% CI | 2.49 - 14.35 | 8.67 - 24.23 | 0.47 - 7.95 | 137.2 - 267.1 | 0.09 - 43.23 | -6.706 - 6.689 | -11.4 - 15.43 | -3.38 - 5.47 | -55.59 - 95.85 | -31.62 - 4.5 | |
| p-Value | 0.0074 | 0.0002 | 0.0291 | < 0.0001 | 0.0491 | 0.998 | 0.7589 | 0.6302 | 0.5877 | 0.1341 | |
| β2: ACE III | Estimate | -0.02829 | -0.2998 | 0.003936 | 1.435 | -0.1792 | -0.019 | -0.03557 | 0.009605 | -0.54 | -0.4134 |
| 95% CI | -0.19 - 0.14 | -0.52 - -0.07 | -0.1 - 0.11 | -0.41 - 3.28 | -0.79 - 0.43 | -0.24 - 0.21 | -0.48 - 0.41 | -0.13 - 0.15 | -3.07 - 1.99 | -1.01 - 0.19 | |
| p-Value | 0.7317 | 0.0101 | 0.9397 | 0.122 | 0.5517 | 0.8623 | 0.8712 | 0.8944 | 0.6634 | 0.1706 | |
| β3: BI | Estimate | -0.3106 | -1.223 | -0.4194 | -10.09 | -3.855 | -0.4503 | 0.4518 | -0.2671 | 3.151 | -2.186 |
| 95% CI | -1.38 - 0.76 | -2.63 - 0.18 | -1.09 - 0.25 | -21.83 - 1.64 | -7.75 - 0.04 | -1.67 - 0.76 | -1.99 - 2.89 | -1.07 - 0.54 | -10.63 - 16.93 | -5.48 - 1.1 | |
| p-Value | 0.5542 | 0.0848 | 0.212 | 0.0884 | 0.0522 | 0.4526 | 0.7055 | 0.4994 | 0.6407 | 0.1823 | |
| β4: FIM | Estimate | 0.0008364 | 0.03768 | 0.01982 | 0.1577 | 0.1575 | -0.009847 | 0.08176 | -0.009425 | -0.3358 | -0.3762 |
| 95% CI | -0.09 - 0.09 | -0.08 - 0.16 | -0.03- 0.07 | -0.84 - 1.15 | -0.18 - 0.49 | -0.11 - 0.09 | -0.12 - 0.29 | -0.07 - 0.05 | -1.5 - 0.83 | -0.65 - -0.09 | |
| p-Value | 0.985 | 0.5199 | 0.4821 | 0.7463 | 0.3347 | 0.845 | 0.4209 | 0.777 | 0.5567 | 0.0101 | |
| β5: BBS | Estimate | -0.07378 | -0.1856 | -0.001744 | 0.4655 | 0.7937 | 0.1786 | 0.361 | 0.103 | -0.7422 | 0.3472 |
| 95% CI | -0.29 - 0.14 | -0.48 - 0.1 | -0.14 - 0.13 | -1.97 - 2.9 | -0.01 - 1.6 | -0.06 - 0.42 | -0.13 - 0.85 | -0.05 - 0.27 | -3.52 - 2.03 | -0.31 - 1 | |
| p-Value | 0.5 | 0.2018 | 0.9797 | 0.6969 | 0.0545 | 0.146 | 0.1425 | 0.2017 | 0.5855 | 0.2893 | |
| β6: SFR | Estimate | -3.899 | 12.23 | 50.6 | 54.62 | 43.15 | 0.2419 | 5.205 | 41.9 | 119.2 | 17.25 |
| 95% CI | -16.44 - 8.64 | -4.22 - 28.69 | 42.69 - 58.52 | -82.83 - 192.1 | -2.47 - 88.77 | -14.65 - 15.14 | -24.63 - 35.04 | 32.06 - 51.74 | -49.16 - 287.6 | -22.92 - 57.43 | |
| p-Value | 0.5264 | 0.1377 | < 0.0001 | 0.4195 | 0.0626 | 0.9735 | 0.7215 | < 0.0001 | 0.1565 | 0.3836 | |
ACE III, Addenbrooke’s Cognitive Examination III; BBS, the Berg Balance Scale; BI, Barthel Index; CI, confidence interval; FIM, functional independence measure; H2O2, hydrogen peroxide; NWS, non-stimulated whole saliva; SFR, salivary flow rate; SWS, stimulated whole saliva; UA, uric acid; XO, xanthine oxidase.